+

HeartBit – A Real Time Wearable Exercise ECG @CES – Sands A-C. Booth # 45938

THE PROBLEM:

Heart disease is the number one cause of death in the United States. Cardiovascular diseases claim more lives than all forms of cancer combined. “Nearly 614,000 Americans die each year from heart disease, stroke and other cardiovascular diseases, accounting for one in every three deaths.”1
Risks of heart diseases are not only e ecting the elderly, but also impacting people doing regular or intensive exercise. “Research estimates range from 0.5 to 2 deaths per 100,000 marathon runners in a given race.”2 In 2015 nearly 18 million people finished long distance running events in the United States.

OUR SOLUTION:

The HeartBit solution (patent pending) indicates the health level of users’ heart muscle by realtime monitoring, recording and analyzing ECG signals - in order to avoid over stress and undesired heart diseases during most physical activities. 

MAJOR CHARACTERISTICS OF OUR WEARABLE REAL TIME EXERCISE ECG:

  • HeartBit is a 3-electrode ECG system integrated into a exible chest strap and a compact measurement device to provide laboratory-like heart muscle analysis.
  • Custom-developed algorithm detects and provides warning about the stress level of your heart (during rest, stress, and recovery states).
  • Real time data assessment detects arrhythmia, atrial fibrillation and potential anomalies during activity.

WHAT MAKES HEARTBIT DIFFERENT: 

TARGET MARKET:

  • Non-professional sport activities (more than 60 million runners/joggers in the US (2015).
  • The road running industry is estimated $1.4 billion annual, which equals to the amount of NFL ticket sales.
  • Leisure and home users, for people with cardiac pre-existing conditions. l Professional individual or team sport activities. 

RECENT DEVELOPMENT & EXITS: 

Professionally veri ed development team in Europe, that previously developed the WIWE system (www.myWIWE.com). WIWE is a small credit card-sized, non-exercise ECG measur- ment device intended for home use. The WIWE technology was sold to a strategic investor in Europe in 2014. 

CURRENT STATUS OF HEARTBIT:

A fully operational prototype (software, hardware, IP) present at CES 2017. For sale to a US marketer/distributor. Documented clinical tests. Mass production transfer documentation available upon request, intended toward submission to FDA. Development team with sig- ni cant experience in product transfer and FDA submissions. 

THE DEVELOPMENT TEAM:

Core team of ve PhD members in Europe, with a focus on mechanical engineering, IT and healthcare. Lead engineer Prof. György Kozmann, Dsc. with over 50 years’ related experience. Supporting team with excellent knowledge of the industry. Extensive research and bioengineering experience in body surface mapping, specialized in cardiac signal detection. Previous work experience from the US (Brigham Young University, UT) and France, under the direction of Nobel laureate Prof. Rudolf Mössbauer.

Applied sources:

1. CDC.gov – Heart Disease Facts, American Heart Association – 2015 Heart Disease and Stroke Update, compiled by AHA, CDC, NIH and other governmental sources

2. http://www.forbes.com/sites/davidkroll/2014/04/15/why-do-healthy-people-die-running-marathons/#44320abf67d8

3. http://www.runningusa.org/state-of-sport-us-trends-2015 

CONTACT

Personal demonstration and detailed project presentation available at CES – Booth # 45938,

[Wearable Health Technologies Inc], Sands A-C.

CEO - György Kozmann, G.Kozmann@TheHeartBit.com 

Print Print | Sitemap
© Wearable Health Technologies Inc. - 1&1 MyWebsite